{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-108716","form_type":"8-K","ticker":"CRMD","cik":"0001410098","company_name":"CorMedix Inc.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.335014+00:00","generated_at":"2026-05-16T20:59:59.600423+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CorMedix reports Q3 net income of $108.6M, raises FY 2025 pro forma revenue guidance to $390-410M","bullets":["Net revenue of $104.3M (pro forma $130.8M) driven by DefenCath sales of $88.8M; diluted EPS $1.26.","FY 2025 pro forma net revenue guidance raised to $390-410M; Q4 guidance $115-135M; adjusted EBITDA guidance $220-240M.","One-time $59.7M tax benefit from NOL carryforwards realization contributed to net income.","Melinta acquisition closed Aug 29; integration ahead of schedule with ~$30M annual synergy run-rate expected by end 2025.","Cash and short-term investments $55.7M at Sept 30; projecting year-end ~$100M; Phase III ReSPECT enrollment completed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-108716","json":"https://secwatch.observer/filing/0001213900-25-108716.json","markdown":"https://secwatch.observer/filing/0001213900-25-108716.md","text":"https://secwatch.observer/filing/0001213900-25-108716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025108716/0001213900-25-108716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025108716/ea0265136-8k_cormedix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:59:59.600423+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}